International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 4 , Pages 868-879 , 15 July 2002

Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers’ experience

Presented in part at the 43rd Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Francisco, CA, November 4–8, 2001.

  • Bruno Cutuli, M.D.

      Affiliations

    • Corresponding Author InformationReprint requests to: Bruno Cutuli, M.D., Department of Radiation Oncology, Polyclinique de Courlancy, 38 rue de Courlancy, Reims 51100 France. Tel: 33-03-26-84-02-84; Fax: 33-03-26-84-70-20
    • Department of Radiation Oncology, Paul Strauss Center Strasbourg and Polyclinique de Courlancy, Reims, France
    • ,
  • Christine Cohen-Solal-le Nir, M.D.

      Affiliations

    • Department of Radiation Oncology, Centre René Huguenin, Saint Cloud, France
    • ,
  • Brigitte de Lafontan, M.D.

      Affiliations

    • Department of Radiation Oncology, Institut Claudius Regaud, Toulouse, France
    • ,
  • Hervé Mignotte, M.D.

      Affiliations

    • Department of Surgery, Centre Léon Bérard, Lyon, France
    • ,
  • Virginie Fichet, M.D.

      Affiliations

    • Department of Radiation Oncology, Institut Paoli Calmettes, Marseille, France
    • ,
  • Renaud Fay, Ph.D.

      Affiliations

    • MRC Statistics, Cernay-les-Reims, France
    • ,
  • Véronique Servent, M.D.

      Affiliations

    • Department of Surgery, Centre Oscar Lombret, Lille, France
    • ,
  • Sylvia Giard, M.D.

      Affiliations

    • Department of Surgery, Centre Oscar Lombret, Lille, France
    • ,
  • Claire Charra-Brunaud, M.D.

      Affiliations

    • Department of Radiation Oncology, Centre Alexis Vautrin, Vandoeuvre les Nancy, France
    • ,
  • Claire Lemanski, M.D.

      Affiliations

    • Department of Radiation Oncology, Centre Val d’Aurelle, Montpellier, France
    • ,
  • Hugues Auvray, M.D.

      Affiliations

    • Department of Radiation Oncology and Pathology, Centre Jean Perrin, Clermont-Ferrand, France
    • ,
  • Stéphane Jacquot, M.D.

      Affiliations

    • Department of Radiation Oncology, Centre Val d’Aurelle, Montpellier, France
    • ,
  • Jean-Christophe Charpentier, M.D.

      Affiliations

    • MRC Statistics, Cernay-les-Reims, France

Received 27 September 2001 ,Revised 11 March 2002 ,Accepted 19 March 2002.

References 

  1. Silverstein MJ. Ductal carcinoma in situ of the breast. Annu Rev Med. 2000;51:17–32
  2. Schwartz GF, Solin LJ, Olivotto IA, et al.  Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22–25, 1999. Cancer. 2000;88:946–954
  3. Winchester DP, Jeske JM, Goldschmidt RA. The diagnosis and management of ductal carcinoma in situ of the breast. Cancer J Clin. 2000;50:184–200
  4. Sakorafas GH, Tsiotou AG. Ductal carcinoma in situ (DCIS) of the breast (Evolving perspectives). Cancer Treat Rev. 2000;26:103–125
  5. Silverstein MJ, Lagios MD, Martino S, et al.  Outcome after invasive local recurrence inpatients with ductal carcinoma in situ of the breast. J Clin Oncol. 1998;16:1367–1373
  6. Bijker N, Peterse JL, Duchateau L, et al.  Risk factor for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ (Analysis of European Organisation for Research and Treatment of Cancer trial 10853). J Clin Oncol. 2001;19:2263–2271
  7. Cutuli B, Cohen-Solal-Le Nir C, de Lafontan B, et al.  Ductal carcinoma in situ of the breast (Results of conservative and radical treatments in 716 patients). Eur J Cancer. 2001;37:2365–2372
  8. Morrow M. The natural history of ductal carcinoma in situ (Implications for clinical decision making). Cancer. 1995;76:1113–1120
  9. Morrow M. Surgical overview of the treatment of ductal carcinoma in situ. In:  Silverstein MJ editors. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins; 1997;p. 469–478
  10. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ (A meta-analysis). Cancer. 1999;85:616–628
  11. Ciatto S, Bonardi R, Cataliotti L, et al.  Intraductal breast carcinoma (Review of a multicenter series of 350 cases). Tumori. 1990;76:552–554
  12. Silverstein MJ. Van Nuys experience by treatment. In:  Silverstein MJ editors. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins; 1997;p. 443–447
  13. Skinner KA, Silverstein MJ. The management of ductal carcinoma in situ of the breast. Ca Cancer J Clin. 2000;50:7–33
  14. Tunon de Lara C, de Mascarel I, MacGrogan G, et al.  Analysis of 676 ductal carcinoma in situ (DCIS) of the breast from 1971 to 1995 (Diagnosis and treatment—The experience of one institute). Am J Clin Oncol. 2001;24:531–536
  15. Ringberg A, Andersson I, Aspegren K, et al.  Breast carcinoma in situ in 167 women (Incidence, mode of presentation, therapy and follow-up). Eur J Surg Oncol. 1991;17:466–476
  16. Arnesson LG, Olsen K. Linköping experience. In:  Silverstein MJ editors. Ductal carcinoma in situ of the breast (section VII: Excision only). Baltimore: Williams & Wilkins; 1997;p. 373–377
  17. Ottesen GL, Graversen HP, Blichert-Toft M, et al.  Carcinoma in situ of the female breast (10-year follow-up results of a prospective nation-wide study). Breast Cancer Res Treat. 2000;62:197–210
  18. Lagios MD. Lagios experience. In:  Silverstein MJ editors. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins; 1997;p. 361–365
  19. Vicini FA, Lacerna MD, Goldstein NS, et al.  Ductal carcinoma in situ detected in the mammographic era (An analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy). Int J Radiat Oncol Biol Phys. 1997;39:627–635
  20. Amalric R, Brandone H, Dubau A, et al.  Résultat du traitement par chirurgie conservatrice et irradiation de 132 carcinomes canalaires in situ non palpable du sein. Cancer Radiother. 1998;2:19–26
  21. Amichetti M, Caffo O, Richetti A, et al.  Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy. Eur J Cancer. 1997;33:1559–1565
  22. Fowble B, Hanlon AL, Fein DA, et al.  Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int J Radiat Oncol Biol Phys. 1997;38:949–957
  23. Denoux Y, Marnay J, Crouet H, et al.  Evaluation des facteurs prédictifs des récidives locales, en particulier de l’index de Van Nuys, dans les carcinomes intracanalaires du sein: étude de 166 cas avec traitement conservateur et revue de la littérature. Bull Cancer. 2001;88:419–425
  24. Schwartz GF. Treatment of subclinical ductal carcinoma in situ by local excision and surveillance (A personal experience). In:  Silverstein MJ editors. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins; 1997;p. 353–360
  25. Hughes KS, Lee AK, Rolfs A. Controversies in the treatment of ductal carcinoma in situ. Surg Clin North Am. 1996;76:243–265
  26. Fisher B, Costantino J, Redmond C, et al.  Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 1993;328:1581–1586
  27. Fisher B, Dignam J, Wolmark N, et al.  Lumpectomy and radiation therapy for the treatment of intraductal breast cancer (Findings from National Surgical Adjuvant Breast and Bowel Project B-17). J Clin Oncol. 1998;16:441–452
  28. Fisher ER, Dignam J, Tan-Chiu E, et al.  Pathologic findings from National Surgical Adjuvant Breast Project (NSABP) (Eight-year update of protocol B-17—Intraductal carcinoma). Cancer. 1999;86:429–438
  29. Julien JP, Bijker N, Fentiman IS, et al.  Radiotherapy in breast-conservative treatment for ductal carcinoma in situ (First results of the EORTC randomized phase III trial 10853). Lancet. 2000;355:528–533
  30. Bijker N, Peterse JL, Duchateau L, et al.  Risk factor for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ (Analysis of European Organisation for Research and Treatment of Cancer trial 10853). J Clin Oncol. 2001;19:2263–2271
  31. Fentiman IS, Julien JP, Von Dongen JA, et al.  Reasons of non-entry of patients with DCIS of the breast into a randomised trial (EORTC 10853). Eur J Cancer. 1991;4:450–452
  32. Bijker N, Rutgers EJ, Peterse JL, et al.  Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast conserving treatment for DCIS. Eur J Surg Oncol. 2001;27:135–140
  33. Farrow JH  Current concepts in the detection and treatment of the earliest of the early breast cancers . Cancer. 1970;25:468–477
  34. Cataliotti L, Distante V, Pacini P, et al.  Florence experience. In:  Silverstein MJ editors. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins; 1997;p. 449–454
  35. Rosner D, Bedwani RN, Vana J, et al.  Non invasive breast carcinoma (Results of a national survey by the American College of Surgeons). Ann Surg. 1980;192:139–147
  36. Ward BA, McKhann CF, Ravikumar TS. Ten-year follow-up of breast carcinoma in situ in Connecticut. Arch Surg. 1992;127:1392–1395
  37. Petit JY, Vilcoq JR, Contesso G, et al.  Le traitement des cancers intracanalaires. In:  Lansac J,  Lefloch O,  Bougnoux P editor. Dépistage du cancer du sein et conséquences thérapeutiques. Paris: Masson; 1989;p. 115–120
  38. Kinne DW, Petrek JA, Osborne MP, et al.  Breast carcinoma in situ. Arch Surg. 1989;124:33–36
  39. Faverly DRG, Burgers L, Bult P, et al.  Three dimensional imaging of mammary ductal carcinoma in situ (Clinical implications). Semin Diag Pathol. 1994;11:193–198
  40. Holland R, Hendriks JHCL, Verbeek ALM, et al.  Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet. 1990;335:519–522
  41. Holland R, Hendriks JHCL. Microcalcifications associated with ductal carcinoma in situ (Mammographic-pathologic correlation). Semin Diag Pathol. 1994;11:181–192
  42. Hwang ES, Esserman LJ. Management of ductal carcinoma in situ. Surg Clin North Am. 1999;79:1007–1030
  43. Amichetti M, Caffo O, Richetti A, et al.  Subclinical ductal carcinoma in situ of the breast (Treatment with conservative surgery and radiotherapy). Tumori. 1999;85:488–493
  44. Barchielli A, Paci E, Giorgi D, et al.  Recent trends of in situ carcinoma of the breast and mammographic screening in the Florence area, Italy. Cancer Causes Control. 1999;10:313–317
  45. Ernster VL, Barclay J, Kerlikowske K, et al.  Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 1996;275:913–918
  46. Ernster VL, Barclay J. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography (A dilemma). J Natl Cancer Inst Mamog. 1997;22:151–156
  47. Kestin LL, Goldstein NS, Martinez AA, et al.  Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy (Patterns of failure and 10 years results). Ann Surg. 2000;231:235–245
  48. Carpenter R, Boulter PS, Cooke T, et al.  Management of screen detected ductal carcinoma in the female breast. Br J Surg. 1989;76:564–567
  49. Solin LJ, Fourquet A, Vicini F, et al.  Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys. 2001;50:991–1102
  50. Early Breast Cancer Trialists’ Collaborative Group . Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer (An overview of the randomized trials). Lancet. 2000;355:1757–1770
  51. Swallow CJ, Van Zee KJ, Sacchini V, et al.  Ductal carcinoma in situ of the breast (Progress and controversy). Curr Probl Surg. 1996;33:553–600
  52. Sibbering DM, Blamey RW. Nottingham experience. In:  Silverstein MJ editors. Ductal carcinoma in situ of the breast. Philadelphia: Williams & Wilkins; 1997;p. 367–372
  53. Holland PA, Gandhi A, Knox WF, et al.  The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ. Br J Cancer. 1998;77:110–114
  54. Hughes KS, Lee AKC, McLellan R, et al.  Breast-conserving therapy for patients with ductal carcinoma in situ. Breast Dis. 1996;7:255–268
  55. Silverstein MJ, Lagios MD, Groshen S, et al.  The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999;340:1455–1461
  56. Warnberg F, Nordgren H, Bergh J. Ductal carcinoma in situ of the breast from a population-defined cohort (An evaluation of new histopathological classification systems). Eur J Cancer. 1999;15:714–720
  57. Hetelekidis S, Collins L, Schnitt SJ, et al.  Predictors of local recurrence following excision alone for ductal carcinoma in situ (DCIS). [Abstract] Int J Radiat Oncol Biol Phys. 1997;39(Suppl.):138
  58. Ciatto S, Grazzini G, Iossa A, et al.  In situ ductal carcinoma of the breast (Analysis of clinical presentation and outcome in 156 consecutive cases). Eur J Surg Oncol. 1990;16:220–224
  59. Jourdain O, Tunon de Lara C, Quenel N, et al.  Les récidives après traitement des carcinomes intracanalaires du sein. J Gynecol Obstet Biol Reprod. 1998;27:403–412
  60. Szelei-Stevens KA, Kuske RR, Yantos VA, et al.  The influence of young age, and positive family history of breast cancer on the prognosis of ductal carcinoma in situ treated by excision with or without radiation therapy or by mastectomy. Int J Radiat Oncol Biol Phys. 2000;48:943–949
  61. Price P, Sinnet HD, Gusterson B, et al.  Duct carcinoma in situ (Predictors of local recurrence and progression in patients treated by surgery alone). Br J Cancer. 1990;61:869–872
  62. Page DL, Dupont WD, Rogers LW, et al.  Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer. 1995;76:1197–1200
  63. Kuske RR, Bean JM, Garcia DM, et al.  Breast conservation therapy for intraductal carcinoma of the breast. Int J Radiat Oncol Biol Phys. 1993;26:391–393
  64. Bonnier P, Body G, Bessenay F, et al.  the Association for Research in Oncologic Gynaecology   Prognostic factors in ductal carcinoma in situ of the breast (Results of a retrospective study of 575 cases). Eur J Obstet Gynecol Reprod Biol. 1999;84:27–35
  65. Ray GR, Adelson J, Hayhurst E, et al.  Ductal carcinoma in situ of the breast (Results of treatment by conservative surgery and definitive irradiation). Int J Radiat Oncol Phys. 1993;28:105–111
  66. Hiramatsu H, Bornstein BA, Recht A, et al.  Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ (Possible importance of family history). Cancer J Sci Am. 1995;1:55–61
  67. Harris EE, Schultz DJ, Peters CA, et al.  Relationship of family history and outcome after breast conservation therapy in women with ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys. 2000;48:933–942
  68. Fourquet A, Zafrani B, Campana F, et al.  Institut Curie experience. In:  Silverstein MJ editors. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins; 1997;p. 391–397
  69. Solin LJ, Haffty B, Fourquet A, et al.  An international collaborative study (15-year experience). In:  Silverstein MJ editors. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins; 1997;p. 385–390
  70. Mirza NQ, Vlastos G, Meric F, et al.  Ductal carcinoma in situ (Long-term results of breast conserving therapy). Ann Surg Oncol. 2000;7:656–664
  71. Ernster VL, Barclay J, Kerlikowske K, et al.  Mortality among women with ductal carcinoma in situ of the breast in the population-based Surveillance, Epidemiology and End Results program. Arch Intern Med. 2000;160:953–958
  72. Lagios MD. Heterogeneity of duct carcinoma in situ (DCIS) (Relationship of grade and subtype analysis to local recurrence and risk of invasive transformation). Cancer Lett. 1995;90:97–102
  73. Choi WS, Parker BA, Pierce JP, et al.  Regional differences in the incidence and treatment of ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 1996;5:317–320
  74. Consensus Conference Committee . Consensus conference on the classification on ductal carcinoma in situ. Cancer. 1997;80:1798–1802
  75. Elston CW, Sloane JP, Amendoeira I, et al.  Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. Eur J Cancer. 2000;36:1769–1772
  76. Holland R, Peterse JL, Millis RR, et al.  Ductal carcinoma in situ (A proposal for a new classification). Semin Diagn Pathol. 1994;11:167–180
  77. Millis RR, Bobrow LG, Barnes DM. Immunohistochemical evaluation of biological markers in mammary carcinoma in situ (Correlation with morphological features and recently proposed schemas for histological classification). Breast. 1996;5:113–122
  78. Page DL, Jensen RA. Evaluation and management of high risk and premalignant lesions of the breast. World J Surg. 1994;18:32–38
  79. Poller DN, Silverstein MJ, Lagios MD, et al.  Use of prognostic index for breast ductal carcinoma in situ (Is excision margin status still the most crucial factor in predicting disease recurrence?). J Pathol. 1996;178(Suppl.):6A
  80. Recht A, Rutgers EJ, Fentiman IS, et al.  The fourth EORTC DCIS consensus meeting (Château Marquette, Heemskerk, The Netherlands 23–24 January 1998) conference report. Eur J Cancer. 1998;34:1664–1669
  81. Schnitt SJ, Harris JR, Smith BL. Developing a prognostic index for ductal carcinoma in situ of the breast (Are we there yet?). Cancer. 1996;77:2189–2192
  82. Silverstein MJ, Lagios MD, Craig PH, et al.  A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996;77:2267–2274
  83. Tavassoli FA. Ductal carcinoma in situ (Introduction of the concept of ductal intraepithelial neoplasia). Mod Pathol. 1998;11:140–154
  84. van de Vijiver MJ. Ductal carcinoma in situ of the breast (Histological classification and genetic alterations). Recent Results Cancer Res. 1998;152:123–134
  85. Zafrani B, Leroyer A, Laurent M, et al.  Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification (A study of 127 cases—Correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity). Semin Diagn Pathol. 1994;11:208–214
  86. Fisher B, Land S, Mamounas E, et al.  Prevention of invasive breast cancer in women with ductal carcinoma in situ (An update of the national surgical adjuvant breast and bowel project experience). Semin Oncol. 2001;28:400–418
  87. Bijker N, Peterse JL, Duchateau L, et al.  Histological type and marker expression of the primary tumor compared with its local recurrence after breast conserving therapy for ductal carcinoma in situ. Br J Cancer. 2001;84:539–544
  88. Cheng L, Alkaisi NK, Gordon NH, et al.  Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease. J Natl Cancer Inst. 1997;89:1356–1360
  89. Fowble B. Conservative surgery and radiation therapy for ductal carcinoma in situ (Overview). In:  Silverstein MJ editors. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins; 1997;p. 479–489
  90. Goldstein NS, Kestin L, Vicini F. Intraductal carcinoma of the breast (Pathologic features associated with local recurrence in patients treated with breast-conserving therapy). Am J Surg Pathol. 2000;24:1058–1067
  91. Jacquemier J, Westermann CD, Mazoujian G, et al.  Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation (Correlation of pathologic parameters with outcome of treatment). Cancer. 1993;71:2532–2542
  92. Bobrow LG, Happerfield LC, Gregory WM, et al.  The classification of ductal carcinoma in situ and its association with biological markers. Semin Diag Pathol. 1994;11:199–207
  93. Badve S, Ahern R, Ward AM, et al.  A long-term comparative study of the ability of five classifications of ductal carcinoma in situ of the breast to predict local recurrence after surgical excision. Hum Pathol. 1992;29:915–923
  94. Douglas-Jones AG, Gupta SK, Attanoos RL, et al.  A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS) (Correlation with grade of associated invasive disease). Histopathology. 1996;29:397–409
  95. Poller DN, Silverstein MJ, Galea M, et al.  Ductal carcinoma in situ of the breast (A proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression). Mod Pathol. 1994;7:257–260
  96. Solin LJ, Yeh IT, Kurtz J, et al.  Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation (Correlation of pathologic parameters with outcome of treatment). Cancer. 1993;71:2532–2542
  97. Van Zee KJ, Liberman L, Samli B, et al.  Long-term follow-up of women with ductal carcinoma in situ treated with breast conserving surgery (The effect of age). Cancer. 1999;86:1757–1767
  98. Vicini FA, Kestin LL, Golstein NS, et al.  Impact of young age on outcome in patients with ductal carcinoma in situ treated with breast-conserving therapy. J Clin Oncol. 2000;18:296–306
  99. Singletary SE. Management of contralateral breast. In:  Silverstein MJ editors. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins; 1997;p. 563–567
  100. Fisher B, Dignam J, Wolmark N, et al.  Tamoxifen in treatment of intraductal breast cancer (National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial). Lancet. 2000;353:1993–2000
  101. Solin LJ, Fourquet A, McCormick B, et al.  Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. Int J Radiat Oncol Biol Phys. 1994;30:3–9
  102. Simmons R, Osborne MP. Treatment of recurrent ductal carcinoma in situ. In:  Silverstein MJ editors. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins; 1997;p. 569–575
  103. Hillner BE, Desch CE, Carlson RW, et al.  Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast. J Clin Oncol. 1996;14:70–77

PII: S0360-3016(02)02834-1

International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 4 , Pages 868-879 , 15 July 2002

Article Tools

* Image Usage & Resolution